Advances in hormone-dependent malignancies

    loading  Checking for direct PDF access through Ovid

Abstract

Advances in hormone-dependent malignancy have led to the introduction of new nontoxic endocrine therapies and meta-analyses and to the more widespread use of adjuvant therapies. Developments in molecular biology have brought us nearer to our hopes for gene therapy in this turnover group.

Related Topics

    loading  Loading Related Articles